Caribou Biosciences Inc logo

CRBU

Caribou Biosciences Inc

$10.18

Earnings Summary

Revenue
$2.66Mn
Net Profits
$-19.09Mn
Net Profit Margins
-716.52%

Highlights

Revenue:

Caribou Biosciences Inc’s revenue jumped 67.97% since last year same period to $2.66Mn in the Q1 2022. On a quarterly growth basis, Caribou Biosciences Inc has generated 192.05% jump in its revenue since last 3-months.

Net Profits:

Caribou Biosciences Inc’s net profit fell -45.06% since last year same period to $-19.09Mn in the Q1 2022. On a quarterly growth basis, Caribou Biosciences Inc has generated -3.3% fall in its net profits since last 3-months.

Net Profit Margins:

Caribou Biosciences Inc’s net profit margin jumped 13.64% since last year same period to -716.52% in the Q1 2022. On a quarterly growth basis, Caribou Biosciences Inc has generated -212.21% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Caribou Biosciences Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.35
EPS Estimate Current Year
-0.35

Highlights

EPS Estimate Current Quarter:

Caribou Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -0.35 - a 2.78% jump from last quarter’s estimates.

EPS Estimate Current Year:

Caribou Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -0.35.

Key Ratios

Key ratios of the Caribou Biosciences Inc post its Q1 2022 earnings

Return on Assets (ROA)
-0.19
Return on Equity (ROE)
-0.38
Dividend Per Share (DPS)
0

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Caribou Biosciences Inc’s return on assets (ROA) stands at -0.19.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Caribou Biosciences Inc’s return on equity (ROE) stands at -0.38.

Dividend Per Share (DPS):

Caribou Biosciences Inc declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-09
-0.35
-0.32
8.57%

Company Information

Organisation
Caribou Biosciences Inc